In Brief: Nicotrol
This article was originally published in The Tan Sheet
Executive Summary
Nicotrol: Cygnus and Pharmacia & Upjohn enter arbitration to settle disputed terms regarding P&U's March purchase of Nicotrol's U.S. manufacturing rights. According to Cygnus, the agreement calls for Pharmacia to pay the company for "existing inventory costs and for certain purchase order commitments"; however, Cygnus and P&U have not been able to come to an agreement on these items. P&U is the worldwide licensee for Nicotrol; Cygnus developed the smoking cessation treatment which, marketed by J&J, went OTC in July 1996 ("The Tan Sheet" July 8, 1996, p. 1)...